A Clinical Study of Sorafenib Combined With Gefitinib for the Treatment of pNET

Clinical trial NCT06592989 · RECRUITING

Trial details

NCT number: NCT06592989
Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Status: RECRUITING
Study type: OBSERVATIONAL

Pancreatic Neuroendocrine Neoplasm Sorafenib Gefitinib

Start date: 2024-09-30
Primary completion: 2026-03-31
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.